BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 20, 2004
View Archived Issues
Esperion Therapeutics plans to develop therapies based on PPARdelta agonists
Read More
Helsinn and Taiho sign an agreement for palonosetron
Read More
Interim data on the effects of GTI-2040 and capecitabine in advanced renal cell cancer
Read More
Once monthly ibandronate found effective in the management of osteoporosis
Read More
New phase II results described for NGD-2000-1 in asthma
Read More
OyaGen, a new company to develop a novel class of HIV drugs
Read More
Sucampo completes a new phase III clinical trial with SPI-0211 in constipation
Read More
Good safety and pharmacokinetic data reported for XP-13512 in healthy volunteers
Read More
Novel antibacterial macrolides under investigation at Janssen
Read More
Vertex claims JAK/CDK2 inhibitors for allergic and immune disorders
Read More
Merck presents new inhibitors of B. anthracis lethal factor
Read More
Galderma describes two series of RAR antagonists for dermatological disorders
Read More
AstraZeneca presents new CRTh2 modulators with utility in respiratory disorders
Read More
New antibacterial PDF inhibitors covered by GSK patent
Read More
NeuroSearch team describes dual nAChR/monoamine transporter modulators
Read More
Xenon Genetics selects clinical candidates for metabolic syndrome program
Read More
Cytos' Immunodrug for nicotine addiction enters phase II trial in smokers
Read More
Women's Health Connecticut adopts use of Digene's DNAwithPap Test
Read More
LUMC and OctoPlus to evaluate new drug for chronic middle ear infection
Read More
Watson launches generic sustained-release bupropion hydrochloride
Read More
Phase III eflornithine trial in superficial bladder cancer discontinued
Read More
PTC Therapeutics raises funds to support development of PTC-124
Read More
CP-690550 demonstrates immunosuppressive potential in mice
Read More
Fujisawa, AtheroGenics to jointly develop transplant rejection treatment AGI-1096
Read More
Revenues increase at Genzyme
Read More
CytRx funds RNA interference research for CMV disease treatment
Read More
WAY-135433 promotes HDL cholesterol increase
Read More
AFP-168, a novel ocular hypotensive candidate
Read More
Academic researchers discover novel SERM with CNS effects
Read More